Fine mapping, gene content, comparative sequencing, and expression analyses support Ctla4 and Nramp1 as candidates for Idd5.1 and Idd5.2 in the nonobese diabetic mouse

被引:89
作者
Wicker, LS
Chamberlain, G
Hunter, K
Rainbow, D
Howlett, S
Tiffen, P
Clark, J
Gonzalez-Munoz, A
Cumiskey, AM
Rosa, RL
Howson, JM
Smink, LJ
Kingsnorth, A
Lyons, PA
Gregory, S
Rogers, J
Todd, JA
Peterson, LB
机构
[1] Addenbrookes Hosp, Cambridge Inst Med Res, Juvenile Diabet Res Fdn, Wellcome Trust Diabet & Inflammat Lab, Cambridge CB2 2XY, England
[2] Wellcome Trust Sanger Inst, Cambridge, England
[3] Merck Res Labs, Dept Pharmacol, Rahway, NJ 07065 USA
关键词
D O I
10.4049/jimmunol.173.1.164
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
At least two loci that determine susceptibility to type 1 diabetes in the NOD mouse have been mapped to chromosome 1, Idd5.1 (insulin-dependent diabetes 5.1) and Idd5.2. In this study, using a series of novel NOD.B10 congenic strains, Idd5.1 has been defined to a 2.1-Mb region containing only four genes, Ctla4, Icos, Als2cr19, and Nrp2 (neuropilin-2), thereby excluding a major candidate gene, Cd28. Genomic sequence comparison of the two functional candidate genes, Ctla4 and Icos, from the B6 (resistant at Idd5.1) and the NOD (susceptible at Idd5.1) strains revealed 62 single nucleotide polymorphisms (SNPs), only two of which were in coding regions. One of these coding SNPs, base 77 of Ctla4 exon 2, is a synonymous SNP and has been correlated previously with type I diabetes susceptibility and differential expression of a CTLA-4 isoform. Additional expression studies in this work support the hypothesis that this SNP in exon 2 is the genetic variation causing the biological effects of Idd5.1. Analysis of additional congenic strains has also localized Idd5.2 to a small region (1.52 Mb) of chromosome 1, but in contrast to the Idd5.1 interval, Idd5.2 contains at least 45 genes. Notably, the Idd5.2 region still includes the functionally polymorphic Nramp1 gene. Future experiments to test the identity of Idd5.1 and Idd5.2 as Ctla4 and Nramp1, respectively, can now be justified using approaches to specifically alter or mimic the candidate causative SNPs.
引用
收藏
页码:164 / 173
页数:10
相关论文
共 30 条
[1]   CHANGES IN CD45 ISOFORM EXPRESSION ACCOMPANY ANTIGEN-INDUCED MURINE T-CELL ACTIVATION [J].
BIRKELAND, ML ;
JOHNSON, P ;
TROWBRIDGE, IS ;
PURE, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (17) :6734-6738
[2]   The derivation of highly germline-competent embryonic stem cells containing NOD-derived genome [J].
Brook, FA ;
Evans, EP ;
Lord, CJ ;
Lyons, PA ;
Rainbow, DB ;
Howlett, SK ;
Wicker, LS ;
Todd, JA ;
Gardner, RL .
DIABETES, 2003, 52 (01) :205-208
[3]   HUMAN IG SUPERFAMILY CTLA-4 GENE - CHROMOSOMAL LOCALIZATION AND IDENTITY OF PROTEIN-SEQUENCE BETWEEN MURINE AND HUMAN CTLA-4 CYTOPLASMIC DOMAINS [J].
DARIAVACH, P ;
MATTEI, MG ;
GOLSTEIN, P ;
LEFRANC, MP .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (12) :1901-1905
[4]   The diabetes susceptibility locus Idd5.1 on mouse chromosome 1 regulates ICOS expression and modulates murine experimental autoimmune encephalomyelitis [J].
Greve, B ;
Vijayakrishnan, L ;
Kubal, A ;
Sobel, RA ;
Peterson, LB ;
Wicker, LS ;
Kuchroo, VK .
JOURNAL OF IMMUNOLOGY, 2004, 173 (01) :157-163
[5]   NOD Idd5 locus controls insulitis and diabetes and overlaps the orthologous CTLA4/IDDM12 and NRAMP1 loci in humans [J].
Hill, NJ ;
Lyons, PA ;
Armitage, N ;
Todd, JA ;
Wicker, LS ;
Peterson, LB .
DIABETES, 2000, 49 (10) :1744-1747
[6]   Iron chelators modulate the fusogenic properties of Salmonella-containing phagosomes [J].
Jabado, N ;
Cuellar-Mata, P ;
Grinstein, S ;
Gros, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (10) :6127-6132
[7]   Further mapping of the Idd5.1 locus for autoimmune diabetes in NOD mice [J].
Lamhamedi-Cherradi, SE ;
Boulard, O ;
Gonzalez, C ;
Kassis, N ;
Damotte, D ;
Eloy, L ;
Fluteau, G ;
Lévi-Strauss, M ;
Garchon, HJ .
DIABETES, 2001, 50 (12) :2874-2878
[8]   Symbolic calculus for volumetric reasoning about process plans [J].
Lee, HM ;
Scott, J ;
Williams, JS ;
Cox, D .
AI EDAM-ARTIFICIAL INTELLIGENCE FOR ENGINEERING DESIGN ANALYSIS AND MANUFACTURING, 1996, 10 (03) :183-198
[9]  
LEE WT, 1990, J IMMUNOL, V144, P3288
[10]  
Lyons P A, 1999, Curr Dir Autoimmun, V1, P208